AbbVie Stock Calculator
Estimate your AbbVie ($ABBV) stock returns over time
AbbVie Investment Calculator
Calculate potential returns on your AbbVie stock investment using historical performance data.
Investment Projection Results
Initial Investment:
—
Hold Period:
—
Expected Annual Return:
—
Future Value:
—
Total Return:
—
What This Means For You
Enter your investment details above to see personalized insights.
Investment Growth Over Time
Frequently Asked Questions
This calculator allows you to project returns on AbbVie stock over time. Input your initial investment, holding period, and return rate. Experiment with different values to see how compounding impacts your potential growth.
AbbVie has demonstrated varying returns across different time periods. The 5Y return of 147.00% provides the most comprehensive historical view. Our weighted average annual return of 86.69% gives more weight to longer-term performance. However, past performance doesn't guarantee future results, and returns can vary significantly year to year.
Several factors can influence AbbVie's stock performance:
- Company earnings and revenue growth
- Market conditions and economic trends
- Industry-specific developments
- Company announcements and news
- Overall market sentiment
The calculator provides two key metrics:
Future Value
The projected value of your investment at the end of your holding period
Total Return
The absolute dollar amount gained or lost, plus the percentage return on your investment
Remember that these are projections based on your inputs and historical data. Actual returns may differ significantly.
Explore More Stock Calculators
Historical Returns
1Y Return
20.35%
2Y Return
46.37%
3Y Return
39.84%
4Y Return
93.24%
5Y Return
147.00%
YTD Return
6.31%
Last Updated: 2025-06-04 14:21:17
AbbVie Information
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Business Classification
Sector
Healthcare
Industry
Drug Manufacturers - General
Location
North Chicago, IL, United States
Company Size
55,000 employees
Website
Resources & Data Sources
Stock data powered by
Yahoo Finance API
Company logos provided by
Parqet Logo API
Market data and calculations are for informational purposes only and should not be considered as financial advice.
